← Leaderboards
Wesley Wierson
Lifengine Animal Health Laboratories Incorporated
$974,933
Attributed
$1,212,433
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $475K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,212,433 · 3
By mechanism
R43$737,433 · 2
R37$475,000 · 1
Top collaborators
- Saad J. Kenderian1 shared
Others in their field
Other Rising Stars on “Cell Therapy”
- Mari Ostendorf · University Of Washington$51,931,230
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Jinsy Andrews · Columbia University Health Sciences$15,416,681
- Suma Babu · Massachusetts General Hospital$14,946,420
- Sabrina Paganoni · Massachusetts General Hospital$14,946,420
- Rino Rappuoli · Washington University$14,702,884
Research focus
Cell TherapyEngineeringTransgenesChimeric Antigen Receptor T CellsCellsIn VivoChimeric Antigen ReceptorT-LymphocyteHematologic NeoplasmsFda ApprovedGenesAllogenicGraft Vs Host DiseaseBiological ModelsHuman EngineeringEngineered T CellsDesignDisease ModelAutologousCanis FamiliarisCar T Cell TherapyDisease RemissionBase PairingB-Lymphocytes
Grant awards (3)
c-MYB overexpression for exhaustion resistant CAR-T cell therapies$400,000
R43 · FY2025 · CA · contact PI
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines$475,000
R37 · FY2023 · CA
A non-viral gene editing platform for cell therapies and translational autoimmune disease modeling$337,433
R43 · FY2022 · TR · contact PI